The Impact of Docosahexaenoic Acid on the Prevention of Necrotizing Enterocolitis in Preterm Neonates

A Clinical Study on the Impact of Docosahexaenoic Acid on the Prevention of Necrotizing Enterocolitis in Preterm Neonates

The study will assess the efficacy of Docosahexaenoic Acid in reducing the incidence of necrotizing enterocolitis in premature infants.

The efficacy of Docosahexaenoic Acid in reducing the incidence of necrotizing enterocolitis in preterm neonates will be evalutaed through measuring its immune-modulatory effect on proinflammatory cytokines.

Inclusion Criteria:

• Preterm neonates having a gestational age equal or less than 34 weeks at birth.
• Weight (less than or equal 1.500 KG)
• Clinically stable to begin enteral feeding

Exclusion Criteria:

• Persistent bleeding at any level.
• Receiving medication to avoid coagulation.
• Persistent vomiting.
• Gastrointestinal malformations.
• Mother taking Omega-3 supplements and planning to breastfeed.